The first monoclonal antibody for cancer
The FDA just approved the first monoclonal antibody for cancer...Rituxan (rituximab) from Genentech.
Rituxan is approved for certain cases of B-cell lymphoma...a malignancy of the antibody-producing B-cells.
Rituxan binds to these malignant cells...allowing the immune system to recognize and eliminate them.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote